Epithelial cells lining the urinary tract not only function as a mucosal barrier but also play an active role in host defense and constitute the first line of defense against uropathogenic bacteria, such as uropathogenic Escherichia coli (UPEC). The uroepithelial cells are activated by uropathogenic bacteria to secrete chemokines and cytokines, such as interleukin-8 (IL-8) and IL-6, and as a result, inflammatory cells are recruited into the tissue (27) . Neutrophils are able to detect and migrate toward concentration gradients of chemotactic substances released by affected tissues or bacterial pathogens. During a urinary tract infection (UTI), neutrophils are the predominant inflammatory cells and are recruited to the site of infection in response to IL-8 (15) . Several in vitro studies have investigated neutrophil migration through transwell inserts using nonpolarized single layers of urinary tract epithelial cells (2, 15) . Neutrophil adhesion to urinary epithelium is mediated by CD11b/ CD18 expressed on neutrophils (2, 23) and ICAM-1 (an adhesive receptor for the CD11b/CD18 integrin) expressed on uroepithelial cells (2) . Neutrophils are an essential part of the innate immune system, and recruitment of these immune cells to infected tissues is crucial during the immune response. However, aberrant activation of neutrophils may also cause damage to normal tissue, for example, by excess release of reactive oxygen species (18, 30) . It was recently shown that IL-8 receptor knockout mice have a defective neutrophil migration response, which resulted in neutrophil accumulation and bacteremia in an experimental UTI model (13) .
The nucleotide ATP is known to be released from cells under stress conditions, and extracellular ATP can be metabolized to adenosine by ectonucleotidases, such as CD39 and CD73 (33) . Adenosine activates four known adenosine receptor subtypes, the A 1 , A 2A , A 2B , and A 3 receptors (12) , of which the A 1 , A 2A , and A 2B receptors are expressed in human urinary tract epithelial cells (25) . Adenosine has been identified as a significant inhibitor of inflammation and cell damage (17) , but the role and significance of adenosine during UTI are not known. One mechanism by which adenosine may affect inflammation is the regulation of neutrophil function. Adenosine has been shown to reduce neutrophil cytotoxic function, including adhesion, oxygen radical production, and production of tumor necrosis factor alpha (TNF-␣) (10, 31) . Interestingly, adenosine does not appear to inhibit all functions of neutrophils to the same extent. While extracellular superoxide release was strongly suppressed, phagocytosis was only moderately inhibited (31) . Neutrophil chemotaxis can be modulated by extracellular ATP and adenosine (6, 11) , and recent studies have shown that ATP is released and adenosine formed at the leading edge of migrating neutrophils to promote cell migration (5) . Stimulation of P2Y 2 receptors and adenosine A 3 receptors has been shown to amplify chemoattractant-induced neutrophil migration (5, 20) . In contrast, activation of adenosine A 2A receptors decreases the tissue-damaging activity of neutrophils by inhibiting the production of cytokines, the generation of superoxide anions, and the expression of adhesion molecules (7, 19) .
The aim of the present study was to evaluate the role of adenosine and A 2A receptor activation in neutrophil migration across a polarized multilayer of human uroepithelial cells that resembles the transitional bladder urothelium.
Immunocytochemistry. UROtsa cells grown on transwell inserts were washed in PBS and fixated with cold 4% formaldehyde for 2 h. The membrane was placed in PBS with 0.2% bovine serum albumin (Sigma-Aldrich) and 10% goat serum (Serotec, Oxford, United Kingdom) for 30 min to block unspecific binding sites. Cells were incubated overnight at 4°C with a mouse monoclonal antibody against the human A 2A receptor (Santa Cruz) diluted 1:50, followed by an Alexa Fluor 488-conjugated goat anti-mouse secondary antibody diluted 1:200 together with Alexa Fluor 546-phalloidin diluted 1:200 (both from Molecular Probes, Eugene, OR) for actin visualization. Control experiments to check the specificity of the anti-A 2A antibody were performed by omitting the primary antibody and adding only the secondary antibody. Fluorescence was examined using a Nikon Eclipse E600 confocal microscope (Nikon, Japan) and Nikon confocal microscope EZ-C1 2.20 software.
IL-8 ELISA analysis. The cell culture medium from the top and bottom wells in the neutrophil migration study was analyzed for IL-8 levels after 3 h. The medium was centrifuged at 5,000 ϫ g for 5 min, and IL-8 was analyzed with the BD OptEIA human IL-8 ELISA (enzyme-linked immunosorbent assay) kit II (BD Biosciences Pharmingen, San Diego, CA). IL-8 was determined by measuring optical density at 450 nm with a Labsystems Multiskan Plus fluorescence spectrophotometer.
Preparation of total RNA and RT-PCR. RNA was isolated from UROtsa cells and neutrophils by using an RNeasy Mini kit (Qiagen Inc., Valencia, CA) according to the manufacturer's instructions. Preparation of total RNA from neutrophils required DNase treatment (Qiagen Inc.). Total RNA from UROtsa cells (1 g) and neutrophils (0.5 g) was converted to cDNA using oligo(dT 16 ) primers (1 M) (Applied Biosystems, Foster City, CA) and the Omniscript RT (reverse transcription) kit (Qiagen Inc.). RNA was controlled for genomic DNA contamination. PCR (reaction volume, 25 l) was performed using Ready-To-Go PCR beads (Amersham Biosciences, Buckinghamshire, United Kingdom). Two microliters of the RT reaction product was mixed with primers (0.5 M) for the A 1 , A 2A , A 2B , or A 3 receptor or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ( Table 1) , and PCR was performed in a thermal cycler (Perkin-Elmer GeneAmp PCR system). PCR was run with initial denaturation for 1 min at 94°C, followed by 35 cycles at 94°C for 1 min, 65°C for 30 s, and 1 min at 72°C, and a final extension at 72°C for 10 min for the A 1 and A 2A receptors. For the A 2B and A 3 receptors, the initial denaturation was run for 4 min at 94°C, followed by 35 cycles at 94°C for 45 s, 60°C for 45 s, and 2 min at 72°C, and a final extension at 72°C for 7 min. PCR products were analyzed by agarose gel (2%) electrophoresis and were visualized by ethidium bromide staining.
Flow cytometric analysis of ICAM-1 and CD11b expression. UROtsa cells were stimulated with IA2 (10 6 CFU/ml) for 24 h as described above. After 24 h of stimulation, the cells were washed with PBS and were incubated with or without 1 M CGS 21680 for 3 h. The cells were washed and detached from the surface by incubation with a 0.25% trypsin-EDTA solution (Gibco Invitrogen). The cells (1.5 ϫ 10 5 ) were resuspended in PBS and were incubated either with a fluorescein isothiocyanate (FITC)-conjugated purified mouse monoclonal antibody against human CD54 (ICAM-1) (Beckman Coulter Inc., CA) or with an FITC-conjugated purified mouse monoclonal IgG1 antibody (Beckman Coulter Inc.) for 30 min in the dark at 4°C. Neutrophils were freshly isolated from peripheral blood obtained from healthy human volunteers. Briefly, the EDTAtreated blood was run on a Polymorphprep density gradient (Axis-Shield PoC AS, Oslo, Norway) according to the manufacturer's instructions. Osmolarity was restored by the addition of 0.45% NaCl. Erythrocytes were removed from the neutrophil suspension by hypotonic lysis. The resulting cell suspension contained Ͼ95% neutrophils as evaluated by microscopic examination. Neutrophils suspended in PBS either were not pretreated or were pretreated with 1 M CGS 21680 for 2 h, followed by stimulation with 0.5 g/ml lipopolysaccharide (LPS) (E. coli serotype 0127:B8; Sigma) for 3 h. Neutrophils (3 ϫ 10 6 ) were resuspended in PBS and were incubated either with an R-phycoerythrin (RPE)-conjugated mouse monoclonal antibody against human CD11b (also known as the C3bi receptor) (Beckman Coulter Inc.) or with Tri-Color-conjugated mouse monoclonal IgG1 (Beckman Coulter Inc.) for 30 min in the dark at 4°C. The cells were washed once with PBS, fixed with 0.1% formaldehyde, and analyzed by flow cytometry (Coulter Epics Altra; Beckman Coulter Inc.). The mean ratios of fluorescence intensity for ICAM-1, CD11b, and IgG1 were calculated and compared.
Analysis of phosphorylated IB␣ by Luminex assay. UROtsa cells were seeded in 24-well plates, and when they were confluent, normal medium was replaced with serum-free medium and cells were incubated for 4 h. , and n indicates the number of independent experiments. Student's unpaired t test or one-sample t test analyses were used when two treatments were compared. For multiple comparisons, analysis of variance (ANOVA), followed by Bonferroni's or Dunnett's posttest, was used. P values of Ͻ0.05 were considered statistically significant.
RESULTS

Establishment of a polarized multilayered uroepithelium.
Light microscopy studies of cross-sectioned UROtsa cells on transwell insert membranes confirmed that UROtsa cells form a multilayered polarized uroepithelium when cultured in serum-free medium (Fig. 1A and B) . Approximately 3 to 4 cell layers were formed, and the cells within the basal cell layer appeared to be smaller than the cells in the upper cell layer.
Multilayered UROtsa cells on transwell inserts were stimulated by the addition of the UPEC strain IA2 to the bottom well. After 24 h, neutrophils were added to the top well, and the number of neutrophils that had migrated was determined in the bottom well after 0, 1, 2, and 3 h. After 2 h, neutrophil migration reached a plateau, and the number of migrating neutrophils was approximately 6-fold higher across cell layers exposed to UPEC than across unstimulated cell layers (Fig. 1C) .
Expression of adenosine receptors. RT-PCRs were performed to study the basal mRNA expression of adenosine receptors in UROtsa cells and neutrophils. As shown in Fig.  2A , transcripts for the A 1 (367 bp), A 2A (245 bp), and A 2B (517 bp) receptor subtypes, but not for the A 3 (337 bp) receptor subtype, were detected in UROtsa cells. The strongest expression was found for the A 2B transcript, while A 1 and A 2A expression was weaker. Transcripts for all four receptor subtypes were observed in neutrophils, in which the expression of the A 2A and A 3 transcripts was clearly stronger than that of the A 1 and A 2B transcripts (Fig. 2B ). Protein expression of the A 2A receptor subtype was confirmed by immunocytochemistry of UROtsa cells grown on transwell inserts (Fig. 2C) . In control experiments, no A 2A immunoreactivity was detected in sections incubated with the secondary antibody only (Fig. 2D) .
Effect of adenosine receptor activation on neutrophil transuroepithelial migration. In order to examine the effect of adenosine receptor activation on UPEC (IA2)-evoked neutrophil transuroepithelial migration, adenosine (10 M; n ϭ 6) or the specific A 2A receptor agonist CGS 21680 (1 M) was added to the top well. The migration of neutrophils was not altered in response to adenosine (Fig. 3A) . However, when cells were stimulated with the A 2A receptor agonist CGS 21680, UPEC-evoked migration was significantly decreased after 1 h (n ϭ 8; P Ͻ 0.01) and 2 h (n ϭ 7; P Ͻ 0.001) (Fig. 3B) . The inhibitory effect of CGS 21680 on migration was abolished in the presence of the A 2A receptor antagonist SCH 58261 (10 nM; n ϭ 2), confirming the involvement of the A 2A receptor subtype (Fig. 3B) . In an attempt to find out whether the observed effects of CGS 21680 were caused by an effect on neutrophils or on UROtsa cells, each cell type was pretreated separately with CGS 21680 before the start of the migration assay. However, migration was not significantly inhibited when only the neutrophils or only the UROtsa cells were pretreated with CGS 21680 (data not shown).
Role of IL-8 in neutrophil transuroepithelial migration. To confirm the role of IL-8 in neutrophil transuroepithelial migration (14), a monoclonal anti-IL-8 antibody (1 g/ml [n ϭ 4] and 10 g/ml [n ϭ 3]) was added to the medium. UPEC (IA2)-induced neutrophil migration was significantly reduced after 1 and 2 h by the addition of the anti-IL-8 antibody (Fig.  4A) . We also measured IL-8 levels in the top and bottom wells of the transwell system to find out if CGS 21680 affects migration by reducing IL-8 production. Increased IL-8 levels were detected in the medium from both the top well (n ϭ 5; P Ͻ 0.01) and the bottom well (n ϭ 5; P Ͻ 0.001) of UPEC-exposed cells analyzed after 3 h (Fig. 4B) . Separate studies showed that most of the IL-8 produced was derived from neutrophils (data not shown). Thus, the high IL-8 levels in the top well are likely caused by the presence of nonmigrating neutrophils in this well. The A 2A receptor agonist CGS 21680 (n ϭ 5) did not affect UPEC-induced IL-8 production either in the top well or in the bottom well (Fig. 4B) . These data suggest that the reduced migration in response to CGS 21680 is not associated with changes in IL-8 levels.
Effect of CGS 21680 on ICAM-1 and CD11b expression. The adhesion molecule ICAM-1 on uroepithelial cells and the neutrophil integrin CD11b are known to play active roles in neutrophil migration during urinary tract infections (2). We next examined whether the decreased neutrophil migration evoked by CGS 21680 was associated with changes in ICAM-1 or CD11b expression. Stimulation of UROtsa cells with UPEC (IA2) increased ICAM-1 expression over that by unstimulated control cells (data not shown). IA2-stimulated UROtsa cells were incubated with CGS 21680 and were analyzed for ICAM-1 expression by flow cytometry. The mean percentage of ICAM-1 fluorescence intensity following stimulation with CGS 21680 was not different (98% Ϯ 8.1%; n ϭ 6) from that of cells without CGS 21680 stimulation (MFI set to 100%) (Fig. 5A) . Stimulation of neutrophils with LPS increased CD11b expression over that by unstimulated control cells (data not shown). To test whether CGS 21680 affected the expression of CD11b, neutrophils were treated with CGS 21680 and LPS and were analyzed by flow cytometry. The mean percentage of CD11b fluorescence intensity increased slightly, but not significantly, following stimulation with CGS 21680 (112% Ϯ 12%; n ϭ 4) over that for cells without CGS 21680 stimulation (set to 100%) (Fig. 5B) . Taken together, these data suggest that neither ICAM-1 nor CD11b expression is affected by CGS 21680. 
Effect of CGS 21680 on phosphorylated IB␣.
The exposure time of CGS 21680 in the transmigration assay is short (2 to 3 h), and in order to be able to detect early anti-inflammatory changes, we measured the levels of phosphorylated cytosolic IB␣. CGS 21680 (1 M) reduced the mean fluorescence intensity of phosphorylated IB␣ from 21 Ϯ 4.3 to 10 Ϯ 0.65 after 7 min (n ϭ 4; P Ͻ 0.05) and from 25 Ϯ 4.7 to 16 Ϯ 2.9 after 15 min (Fig. 6A) . UPEC (IA2; 10 8 CFU/ml)-stimulated UROtsa cells (n ϭ 4) and TNF-␣-stimulated HeLa cells (n ϭ 3) were used as positive controls; as expected, these cells showed increased levels of phosphorylated IB␣ (Fig. 6B) . These data suggest that CGS 21680 may inhibit NF-B signaling pathways.
DISCUSSION
Many previous studies of neutrophil transuroepithelial migration have been performed using the A498 kidney (2, 15) and J82 bladder (2) epithelial cells, but these cells form a nonpolarized monolayer. The use of multilayered uroepithelial cells for migration studies better mimics the real scenario of UTI, where neutrophils are migrating across several layers of cells to reach the bladder lumen. UROtsa cells have previously been reported to form polarized multilayers (24) , and we confirmed that these cells were able to form three to four layers when cultured under serum-free conditions on transwell inserts. It was shown that UPEC strain IA2 induced a consistent increase in the number of migrating neutrophils during the first 2 h, but then the migration reached a plateau. Neutrophil migration was minor across cell layers that had not been exposed to UPEC. The chemokine IL-8 is produced by urinary tract epithelial cells and neutrophils during inflammation (1, 21) and is known to be involved in neutrophil transuroepithelial migration (14) . We have previously shown that UROtsa cells grown in a monolayer produce increased IL-8 levels when stimulated for 24 h with UPEC strain IA2 (26) . In the present study, increased IL-8 production in response to UPEC infection was confirmed by greater accumulation of IL-8 in the bottom well of the transwell system for infected cells than for uninfected cells. In addition, monoclonal antibodies against IL-8 almost completely blocked UPEC-induced neutrophil migration, suggesting that IL-8 has a major role as a chemoattractant in transuroepithelial migration. These results are in agreement with those of a similar study conducted on monolayers of urinary tract epithelial cells infected with the E. coli strain Hu734 (15) . The high levels of IL-8 noted in the top well after 3 h are likely caused by the accumulated basal release of IL-8 from the many nonmigrating neutrophils in the top well at this time point. Thus, after 3 h, the IL-8 gradient, promoting unidirectional migration of neutrophils, is no longer present. The time course study for the migration also reveals that the migration shows a plateau after 2 to 3 h, indicating that the IL-8 gradient has ceased. Several studies performed on neutrophils have demonstrated that the production of cytokines and free radicals, as well as the expression of adhesion molecules, is decreased by activation of the adenosine A 2A receptor (7, 19, 31) . Stimulation of neutrophils and UROtsa cells with the specific A 2A receptor agonist CGS 21680 reduced the migration of neutrophils across the UROtsa cell layer after both 1 and 2 h. The reduced migration evoked by CGS 21680 was attenuated by an A 2A receptor antagonist, suggesting that the inhibition was due to activation of the A 2A receptor. Additional experiments, in which the neutrophils and the UROtsa cells were pretreated separately with CGS 21680 before the start of the migration assay, were performed to find out if CGS 21680 affected mainly neutrophils or UROtsa cells. However, significant inhibition of neutrophil migration was seen only when neutrophils and UROtsa cells were coincubated with CGS 21680, suggesting that the reduced CGS 21680-mediated migration involves A 2A receptors both on neutrophils and on uroepithelial cells. RT-PCR data showed that the A 2A receptor is expressed at high levels in neutrophils, whereas A 2A receptor transcript levels were low in UROtsa cells. However, A 2A receptor protein was demonstrated in UROtsa cells by immunocytochemistry. Although the specific A 2A receptor agonist CGS 21680 reduced migration, adenosine was not able to affect UPEC-evoked neutrophil migration. A likely explanation is that adenosine activates adenosine receptors other than the A 2A receptor subtype-for example, the high-affinity A 1 subtype. Activation of both A 1 and A 3 receptors on neutrophils has been shown to mediate and amplify neutrophil migration (5, 8, 20) . Thus, an inhibitory effect of adenosine on A 2A receptors is likely to be masked by activation of the A 1 and A 3 receptors, which stimulates neutrophil migration.
Experiments were performed to investigate whether the reduced migration evoked by CGS 21680 involved changes in the levels of chemotactic IL-8. However, stimulation of the A 2A receptor by CGS 21680 was not able to modulate the IL-8 production evoked by UPEC. These data suggest that changes in IL-8 levels cannot explain the decreased migration evoked by CGS 21680. In agreement with our data, McColl et al. (21) . showed that neither adenosine nor A 2A receptor activation is able to downregulate LPS-induced IL-8 expression and production in neutrophils. However, in contrast to our findings, A 2A receptor activation did not affect neutrophil movement, at least not toward N-formyl-methionyl-leucyl-phenylalanine (fMLP), IL-8, or leukotriene B 4 (21) .
To further elucidate the mechanism by which A 2A receptor activation reduces neutrophil migration, we examined whether the expression of the adhesion molecule ICAM-1 was altered upon exposure to CGS 21680. Stimulation of A 2A receptors has previously been shown to decrease ICAM-1 immunoreactivity in kidney peritubular capillaries and also to reduce neutrophil infiltration in kidney tissue (22) . Our results showed that UPEC-evoked ICAM-1 expression was unaltered by CGS 21680. Besides ICAM-1, there are several additional candidate epithelial receptors for migrating neutrophils, such as the immunoglobulin superfamily (IgSF) members junctional adhesion molecules and CD47 (34) . However, the knowledge of these molecules in urinary tract epithelium and of their regulation by adenosine is limited. ICAM-1 on uroepithelial cells binds to the CD11b/CD18 counterpart on neutrophils (2), and A 2 receptor activation has previously been shown to inhibit fMLP-induced upregulation of CD11b/CD18 expression in neutrophils (32) . However, in that study, the nonselective A 2 agonist 5Ј-N-ethylcarboxamidoadenosine was used, and the involvement of the A 2A receptor is therefore uncertain. We studied the effect of A 2A receptor activation on LPS-induced CD11b expression in neutrophils, but decreased expression of CD11b could not be confirmed using the selective A 2A agonist CGS 21680. However, the expression of CD11b on the neutrophil surface does not necessarily reflect the functional capacity of neutrophils, since our experiments give no information on the affinity state or the signaling capacity of CD11b. Moreover, it is possible that changes in the expression of adhesion molecules are difficult to detect within the short 3-h study period used in this study.
Another mechanism known to reduce the adhesion and transmigration of neutrophils is inhibition of NF-B signaling (29) . In this study, we measured the levels of phosphorylated cytosolic IB␣ protein in UROtsa cells as an early marker for Increased knowledge of endogenous mediators, such as adenosine, that regulate and limit neutrophil activation is of interest, since these are potential targets for inflammatory diseases associated with unchecked neutrophil activation. The significance of adenosine in the protection from neutrophilderived cytotoxicity was reported to be substantial; inactivation of adenosine increased cytotoxicity toward endothelial cells by 40 to 70% (9) . UPEC infection of IL-8 receptor knockout mice was recently shown to result in bacteremic pyelonephritis and renal scarring due to a dysfunctional neutrophil response (16, 28) . Taken together, our results demonstrate that A 2A receptor activation regulates neutrophil migration across human uroepithelial cells in vitro. Further studies are needed to elucidate the significance of A 2A receptor signaling for neutrophil migration during UTI.
